ECSP21060381A - Métodos para purificar un extracto de alérgeno - Google Patents

Métodos para purificar un extracto de alérgeno

Info

Publication number
ECSP21060381A
ECSP21060381A ECSENADI202160381A ECDI202160381A ECSP21060381A EC SP21060381 A ECSP21060381 A EC SP21060381A EC SENADI202160381 A ECSENADI202160381 A EC SENADI202160381A EC DI202160381 A ECDI202160381 A EC DI202160381A EC SP21060381 A ECSP21060381 A EC SP21060381A
Authority
EC
Ecuador
Prior art keywords
allergen extract
purify
methods
allergen
purified
Prior art date
Application number
ECSENADI202160381A
Other languages
English (en)
Inventor
María Morales
Marta Román-Escutia
María Teresa Gallego
SÁNCHEZ Jerónimo CARNÉS
Original Assignee
Leti Pharma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Pharma S L filed Critical Leti Pharma S L
Publication of ECSP21060381A publication Critical patent/ECSP21060381A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Insects & Arthropods (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a procesos para producir extractos de alérgenos semipurificados y purificados y composiciones farmacéuticas y vacunas para uso en el diagnóstico y tratamiento de alergia. En un aspecto de la invención, se proporciona un proceso para producir un extracto de alérgeno despigmentado, el proceso que comprende: a) basificar un extracto de alérgeno nativo; y b) remover moléculas que tienen un tamaño molecular de menos de 3.5 kDa; y c) ajustar el pH a neutralidad; para producir de este modo un extracto de alérgeno despigmentado.
ECSENADI202160381A 2019-01-17 2021-08-16 Métodos para purificar un extracto de alérgeno ECSP21060381A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382030 2019-01-17

Publications (1)

Publication Number Publication Date
ECSP21060381A true ECSP21060381A (es) 2021-11-18

Family

ID=65279503

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202160381A ECSP21060381A (es) 2019-01-17 2021-08-16 Métodos para purificar un extracto de alérgeno

Country Status (16)

Country Link
US (1) US20220110983A1 (es)
EP (1) EP3911343A1 (es)
JP (1) JP2022523647A (es)
CN (1) CN113825518A (es)
AU (1) AU2019422413A1 (es)
BR (1) BR112021014064A2 (es)
CA (1) CA3126499A1 (es)
CL (1) CL2021001889A1 (es)
CO (1) CO2021010606A2 (es)
CR (1) CR20210432A (es)
EC (1) ECSP21060381A (es)
IL (1) IL284901A (es)
JO (1) JOP20210197A1 (es)
MX (1) MX2021008665A (es)
PE (1) PE20212105A1 (es)
WO (1) WO2020147985A1 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083497A3 (en) * 1982-01-06 1985-11-06 Beecham Group Plc Process for preparing modified allergens, their use in treating allergic conditions
WO1993001213A1 (en) * 1991-07-12 1993-01-21 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
JP3124344B2 (ja) * 1991-11-06 2001-01-15 フマキラー株式会社 重合ダニアレルゲン
DE69217395T2 (de) 1992-09-21 1997-05-22 Leti Lab Verfahren zur reinigung von waessrigen extrakten, die allergenische proteine enthalten, so erhaltene extrakte und ihre verwendung
CA2145169C (en) * 1992-09-21 2003-05-27 Lubertus Berrens A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
AU2003251674B2 (en) * 2002-08-19 2009-09-03 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
PL1610820T5 (pl) * 2003-04-04 2014-01-31 Genentech Inc Preparaty zawierające wysokoskoncentrowane przeciwciała i białka
CA2789174C (en) * 2010-02-12 2021-08-24 Laboratorios Leti, S.L. Unipersonal Process for producing an allergen extract
FI20115374A0 (fi) * 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
CN102552900A (zh) * 2011-12-21 2012-07-11 北京新华联协和药业有限责任公司 蒿属花粉变应原疫苗及其制备方法和应用
CN103966292A (zh) * 2013-01-31 2014-08-06 中国食品发酵工业研究院 一种过敏原部分消除的适度水解酪蛋白肽工业化制造方法及其应用
ES2503516B1 (es) * 2013-04-03 2015-09-09 Inmunotek, S.L. Complejo inmunogénico para vacunación y método de obtención

Also Published As

Publication number Publication date
JP2022523647A (ja) 2022-04-26
EP3911343A1 (en) 2021-11-24
CA3126499A1 (en) 2020-07-23
CO2021010606A2 (es) 2021-10-29
CL2021001889A1 (es) 2022-01-21
CR20210432A (es) 2022-01-05
AU2019422413A1 (en) 2021-08-26
MX2021008665A (es) 2021-10-26
US20220110983A1 (en) 2022-04-14
PE20212105A1 (es) 2021-11-04
WO2020147985A1 (en) 2020-07-23
JOP20210197A1 (ar) 2023-01-30
IL284901A (en) 2021-08-31
BR112021014064A2 (pt) 2021-09-21
CN113825518A (zh) 2021-12-21

Similar Documents

Publication Publication Date Title
EA201990071A1 (ru) Композиция пептидной вакцины
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
WO2018115527A3 (en) Mers coronavirus vaccine
WO2018033254A3 (en) Rna for cancer therapy
AU2018270408A1 (en) Methods of inhibiting aging and treating aging-related disorders
CL2018002826A1 (es) Proteínas f de prefusión del virus respiratorio sincicial (vrs) solubles y estabilizadas
PH12018502634A1 (en) Topical compositions of apremilast
CO6501190A2 (es) Vacuna de pcsk9
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
BR112012020953A2 (pt) produto, uso do mesmo, metodo para prevencao e/ou tratamento de fibrose corneana ou opacidade corneana e composicao farmaceutica oftalmica
WO2017200659A3 (en) A method to enhance wound healing using silk-derived protein
BR112017023391A2 (pt) ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele?
ECSP21043895A (es) Derivados de oxopiridina sustituidos
AR101871A1 (es) Composiciones de glicoconjugado inmunogénico / terapéutico y sus usos
MX2021003849A (es) Estimación del movimiento usando datos auxiliares en 3d.
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
EA202091769A1 (ru) Вакцины против вируса гриппа и пути их применения
AR095076A1 (es) Péptidos y composiciones para el tratamiento de daño articular
EA201892322A1 (ru) Способ лечения или предупреждения остеоартрита
EP3925968A3 (en) Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
BR102016012501A2 (pt) peptídeo, composição farmacêutica, uso do peptídeo, e, uso da composição farmacêutica
EA202090164A1 (ru) Изотретиноиновые перорально-слизистые композиции и способы их применения
ECSP21060381A (es) Métodos para purificar un extracto de alérgeno
EA201892320A1 (ru) Способ лечения или предупреждения остеоартрита
CL2019002020A1 (es) Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer.